Accuri Cytometers
Latest round
- Series E
Last raised
- Jul 2010
Total raised
- $28M
Investors
- 6
About Accuri Cytometers
Accuri Cytometers, Inc., founded in 2004 in Ann Arbor, US, specializes in flow cytometry technology. The company underwent a significant transition when it was acquired by Becton, Dickinson and Company following Baird Venture Partners' exit in February 2011.Accuri Cytometers, Inc. offers a range of flow cytometry instruments and reagents designed for precise cell analysis in both research and clinical environments. Their key products include the BD FACSDiscover™ A8 Cell Analyzer and the BD Rhapsody™ single-cell analysis systems, which facilitate detailed gene expression studies.Accuri Cytometers generates revenue primarily through direct sales of its sophisticated instruments and reagents, complemented by service contracts. The B2B transaction model often involves bulk orders from clients requiring laboratory analysis equipment. The firm's flagship products play a crucial role in revenue generation, typically offered with bundled service options to enhance efficiency.Accuri Cytometers plans to innovate with upcoming products focused on enhancing flow cytometry capabilities, with specific release dates yet to be announced. The company is looking to expand its market presence in Asia-Pacific and Europe, targeting completion of this expansion strategy by 2015.
Who invested in Accuri Cytometers
6 investors across 4 rounds
See all investors in Accuri Cytometers
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Accuri Cytometers
Who invested in Accuri Cytometers?
Accuri Cytometers has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Accuri Cytometers raised?
Accuri Cytometers has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Accuri Cytometers last raise money?
Accuri Cytometers's most recent round on record is a Series E, in Jul 2010.
What does Accuri Cytometers do?
Accuri Cytometers is a biotechnology company.
Where is Accuri Cytometers headquartered?
Accuri Cytometers is headquartered in Ann Arbor, US.
Which VCs invest in companies like Accuri Cytometers?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Accuri Cytometers's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Accuri Cytometers? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.